Commonwealth Equity Services LLC Buys 2,057 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

Commonwealth Equity Services LLC lifted its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 3.1% in the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 67,539 shares of the medical equipment provider’s stock after acquiring an additional 2,057 shares during the quarter. Commonwealth Equity Services LLC’s holdings in Intuitive Surgical were worth $30,045,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other hedge funds also recently made changes to their positions in the company. Norges Bank bought a new stake in Intuitive Surgical in the fourth quarter worth approximately $1,313,238,000. Capital Research Global Investors bought a new stake in Intuitive Surgical in the first quarter worth approximately $374,390,000. Assenagon Asset Management S.A. grew its stake in Intuitive Surgical by 111.7% in the first quarter. Assenagon Asset Management S.A. now owns 1,285,565 shares of the medical equipment provider’s stock valued at $513,056,000 after acquiring an additional 678,375 shares during the period. Coatue Management LLC grew its stake in Intuitive Surgical by 65.7% in the fourth quarter. Coatue Management LLC now owns 1,301,595 shares of the medical equipment provider’s stock valued at $439,106,000 after acquiring an additional 516,054 shares during the period. Finally, Vanguard Group Inc. grew its stake in Intuitive Surgical by 1.6% in the first quarter. Vanguard Group Inc. now owns 30,868,620 shares of the medical equipment provider’s stock valued at $12,319,358,000 after acquiring an additional 493,126 shares during the period. 83.64% of the stock is currently owned by institutional investors.

Analyst Upgrades and Downgrades

A number of brokerages have commented on ISRG. Citigroup raised their price objective on Intuitive Surgical from $512.00 to $560.00 and gave the company a “buy” rating in a research note on Thursday, August 22nd. BTIG Research lifted their target price on Intuitive Surgical from $469.00 to $494.00 and gave the company a “buy” rating in a research report on Wednesday, August 28th. Robert W. Baird lifted their target price on Intuitive Surgical from $487.00 to $503.00 and gave the company an “outperform” rating in a research report on Friday, July 19th. JPMorgan Chase & Co. lifted their target price on Intuitive Surgical from $475.00 to $495.00 and gave the company an “overweight” rating in a research report on Friday, July 19th. Finally, Morgan Stanley upped their price objective on Intuitive Surgical from $375.00 to $460.00 and gave the company an “equal weight” rating in a research note on Monday, July 15th. Six equities research analysts have rated the stock with a hold rating and fifteen have given a buy rating to the company. According to MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average target price of $446.45.

Insider Buying and Selling

In related news, EVP Robert Desantis sold 188 shares of the firm’s stock in a transaction that occurred on Thursday, August 29th. The stock was sold at an average price of $482.21, for a total transaction of $90,655.48. Following the transaction, the executive vice president now directly owns 5,506 shares in the company, valued at approximately $2,655,048.26. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink. In related news, EVP Robert Desantis sold 188 shares of the firm’s stock in a transaction that occurred on Thursday, August 29th. The stock was sold at an average price of $482.21, for a total transaction of $90,655.48. Following the transaction, the executive vice president now directly owns 5,506 shares in the company, valued at approximately $2,655,048.26. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink. Also, Director Craig H. Barratt sold 1,400 shares of the firm’s stock in a transaction that occurred on Wednesday, June 5th. The stock was sold at an average price of $411.00, for a total value of $575,400.00. The disclosure for this sale can be found here. Insiders have sold a total of 53,056 shares of company stock worth $25,276,044 in the last ninety days. 0.90% of the stock is owned by insiders.

Intuitive Surgical Trading Up 1.1 %

Shares of Intuitive Surgical stock opened at $492.63 on Monday. The firm has a market capitalization of $175.06 billion, a PE ratio of 88.92, a price-to-earnings-growth ratio of 5.43 and a beta of 1.39. The business’s 50-day moving average price is $454.69 and its 200-day moving average price is $414.94. Intuitive Surgical, Inc. has a 12 month low of $254.85 and a 12 month high of $493.97.

Intuitive Surgical (NASDAQ:ISRG) last posted its quarterly earnings results on Thursday, July 18th. The medical equipment provider reported $1.78 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.54 by $0.24. Intuitive Surgical had a return on equity of 13.04% and a net margin of 27.65%. The business had revenue of $2.01 billion for the quarter, compared to analyst estimates of $1.97 billion. During the same period last year, the company earned $1.18 EPS. Intuitive Surgical’s revenue for the quarter was up 14.5% compared to the same quarter last year. As a group, analysts predict that Intuitive Surgical, Inc. will post 5.22 earnings per share for the current fiscal year.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.